These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38587187)

  • 1. Structure-Based Design and Synthesis of Lipid A Derivatives to Modulate Cytokine Responses.
    Verpalen ECJM; Brouwer AJ; Wolfert MA; Boons GJ
    Chemistry; 2024 Jun; 30(32):e202400429. PubMed ID: 38587187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
    Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
    Front Immunol; 2021; 12():631797. PubMed ID: 33815382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2.
    Ohto U; Fukase K; Miyake K; Shimizu T
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7421-6. PubMed ID: 22532668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold.
    Garate JA; Stöckl J; Fernández-Alonso Mdel C; Artner D; Haegman M; Oostenbrink C; Jiménez-Barbero J; Beyaert R; Heine H; Kosma P; Zamyatina A
    Innate Immun; 2015 Jul; 21(5):490-503. PubMed ID: 25394365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner.
    Wong SW; Kwon MJ; Choi AM; Kim HP; Nakahira K; Hwang DH
    J Biol Chem; 2009 Oct; 284(40):27384-92. PubMed ID: 19648648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways.
    Dejkhamron P; Thimmarayappa J; Kotlyarevska K; Sun J; Lu C; Bonkowski EL; Denson LA; Menon RK
    Mol Cell Endocrinol; 2007 Aug; 274(1-2):35-42. PubMed ID: 17601656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialyl residues modulate LPS-mediated signaling through the Toll-like receptor 4 complex.
    Feng C; Stamatos NM; Dragan AI; Medvedev A; Whitford M; Zhang L; Song C; Rallabhandi P; Cole L; Nhu QM; Vogel SN; Geddes CD; Cross AS
    PLoS One; 2012; 7(4):e32359. PubMed ID: 22496731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of innate immune responses with synthetic lipid A derivatives.
    Zhang Y; Gaekwad J; Wolfert MA; Boons GJ
    J Am Chem Soc; 2007 Apr; 129(16):5200-16. PubMed ID: 17391035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of lipid A variants by the TLR4-MD-2 receptor complex.
    Maeshima N; Fernandez RC
    Front Cell Infect Microbiol; 2013; 3():3. PubMed ID: 23408095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for inflammatory diseases.
    Chen L; Fu W; Zheng L; Wang Y; Liang G
    Drug Discov Today; 2018 Jun; 23(6):1187-1202. PubMed ID: 29330126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A.
    Yamakawa N; Ohto U; Akashi-Takamura S; Takahashi K; Saitoh S; Tanimura N; Suganami T; Ogawa Y; Shibata T; Shimizu T; Miyake K
    Int Immunol; 2013 Jan; 25(1):45-52. PubMed ID: 22962435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of monophosphoryl lipid A using 2-naphtylmethyl ethers as permanent protecting groups.
    Verpalen ECJM; Brouwer AJ; Boons GJ
    Carbohydr Res; 2020 Dec; 498():108152. PubMed ID: 33032087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2.
    Kim SY; Koo JE; Seo YJ; Tyagi N; Jeong E; Choi J; Lim KM; Park ZY; Lee JY
    Br J Pharmacol; 2013 Apr; 168(8):1933-45. PubMed ID: 23231684
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Lembo-Fazio L; Billod JM; Di Lorenzo F; Paciello I; Pallach M; Vaz-Francisco S; Holgado A; Beyaert R; Fresno M; Shimoyama A; Lanzetta R; Fukase K; Gully D; Giraud E; Martín-Santamaría S; Bernardini ML; Silipo A
    Front Immunol; 2018; 9():1888. PubMed ID: 30154796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of the host response to lipopolysaccharide.
    Bryant CE; Spring DR; Gangloff M; Gay NJ
    Nat Rev Microbiol; 2010 Jan; 8(1):8-14. PubMed ID: 19946286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid A from lipopolysaccharide recognition: structure, dynamics and cooperativity by molecular dynamics simulations.
    Garate JA; Oostenbrink C
    Proteins; 2013 Apr; 81(4):658-74. PubMed ID: 23184816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor activation of human cells by synthetic triacylated lipid A-like molecules.
    Dunn-Siegrist I; Tissières P; Drifte G; Bauer J; Moutel S; Pugin J
    J Biol Chem; 2012 May; 287(20):16121-31. PubMed ID: 22433865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane.
    Tanimura N; Saitoh S; Ohto U; Akashi-Takamura S; Fujimoto Y; Fukase K; Shimizu T; Miyake K
    Int Immunol; 2014 Jun; 26(6):307-14. PubMed ID: 24380872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical Hybridization of Vizantin and Lipid A to Generate a Novel LPS Antagonist.
    Yamamoto H; Oda M; Kanno M; Tamashiro S; Tamura I; Yoneda T; Yamasaki N; Domon H; Nakano M; Takahashi H; Terao Y; Kasai Y; Imagawa H
    Chem Pharm Bull (Tokyo); 2016; 64(3):246-57. PubMed ID: 26725501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.